Non-histones such as X-ray repair cross-complementing 1 (XRCC1) undergo lactylation at the lysine 247 site (K247), which enhances transport to the cell nucleus and strengthens DNA repair capacity, thereby mediating glioblastoma resistance to therapy [211]. The gene discussed is XRCC1; the disease is glioblastoma.